Beijing Haitian Ruisheng Science Technology Ltd. (SHA:688787)
China · Delayed Price · Currency is CNY 122.85
-9.78 (-7.37%)
Oct 30, 2026, 3:00 PM CST
SHA:688787 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 432.91 | 376.97 | 237.08 | 170.01 | 262.89 | 206.48 |
| 432.91 | 376.97 | 237.08 | 170.01 | 262.89 | 206.48 | |
Revenue Growth | 34.50% | 59.00% | 39.45% | -35.33% | 27.32% | -11.53% |
Cost of Revenue | 228.4 | 198.34 | 79.81 | 75.92 | 92.97 | 76.66 |
Gross Profit | 204.51 | 178.64 | 157.27 | 94.09 | 169.92 | 129.82 |
Selling, General & Admin | 104.55 | 102.46 | 88.93 | 89.5 | 82.13 | 49.74 |
Research & Development | 63.56 | 58.59 | 63.44 | 57.01 | 91.91 | 60.52 |
Other Operating Expenses | -3.07 | 1.7 | -0.52 | 2.66 | 1.34 | -6.71 |
Operating Expenses | 167.02 | 168.72 | 153.42 | 157 | 177.16 | 106.51 |
Operating Income | 37.49 | 9.92 | 3.85 | -62.91 | -7.25 | 23.3 |
Interest Expense | -0.06 | -0.26 | -0.27 | -0.07 | -0.01 | -0.15 |
Interest & Investment Income | 1.77 | 5.85 | 7.12 | 10.52 | 14.1 | 11.64 |
Currency Exchange Gain (Loss) | -1.28 | -1.28 | -0.46 | -0.01 | 4.74 | -1.04 |
Other Non Operating Income (Expenses) | -13.18 | -0.53 | -0.57 | -0.34 | -0.69 | -0.29 |
EBT Excluding Unusual Items | 24.73 | 13.7 | 9.66 | -52.81 | 10.88 | 33.46 |
Gain (Loss) on Sale of Investments | -0.12 | 0.4 | 0.58 | -0.64 | -0.06 | -0.08 |
Gain (Loss) on Sale of Assets | 0 | -0.01 | 0.03 | -0.22 | 0.3 | -0.07 |
Other Unusual Items | 0.24 | -1.27 | 0.32 | 12.82 | 17.24 | 0.51 |
Pretax Income | 23.39 | 12.82 | 10.59 | -40.85 | 28.36 | 33.82 |
Income Tax Expense | 1.72 | -2.27 | -0.73 | -10.47 | -1.09 | 2.22 |
Earnings From Continuing Operations | 21.67 | 15.08 | 11.32 | -30.39 | 29.45 | 31.61 |
Minority Interest in Earnings | -1.27 | -0.97 | 0.02 | - | - | - |
Net Income | 20.4 | 14.12 | 11.34 | -30.39 | 29.45 | 31.61 |
Net Income to Common | 20.4 | 14.12 | 11.34 | -30.39 | 29.45 | 31.61 |
Net Income Growth | 73.95% | 24.54% | - | - | -6.81% | -61.49% |
Shares Outstanding (Basic) | 58 | 59 | 60 | 61 | 60 | 50 |
Shares Outstanding (Diluted) | 58 | 59 | 60 | 61 | 60 | 50 |
Shares Change | 0.95% | -1.40% | -1.82% | 1.10% | 20.90% | 10.76% |
EPS (Basic) | 0.35 | 0.24 | 0.19 | -0.50 | 0.49 | 0.64 |
EPS (Diluted) | 0.35 | 0.24 | 0.19 | -0.50 | 0.49 | 0.64 |
EPS Growth | 72.31% | 26.32% | - | - | -22.92% | -65.24% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.19 | -31.44 | -2.62 | -56.98 | -226.57 | -23.95 |
Free Cash Flow Per Share | -0.66 | -0.53 | -0.04 | -0.94 | -3.77 | -0.48 |
Dividend Per Share | 0.100 | 0.100 | 0.350 | - | 0.429 | 0.179 |
Dividend Growth | -71.43% | -71.43% | - | - | 139.98% | - |
Gross Margin | 47.24% | 47.39% | 66.33% | 55.35% | 64.63% | 62.87% |
Operating Margin | 8.66% | 2.63% | 1.62% | -37.00% | -2.76% | 11.29% |
Profit Margin | 4.71% | 3.74% | 4.78% | -17.87% | 11.20% | 15.31% |
Free Cash Flow Margin | -8.82% | -8.34% | -1.10% | -33.52% | -86.19% | -11.60% |
EBITDA | 48.99 | 23.48 | 20.15 | -48.74 | -1.49 | 26.2 |
EBITDA Margin | 11.32% | 6.23% | 8.50% | -28.67% | -0.57% | 12.69% |
D&A For EBITDA | 11.5 | 13.56 | 16.3 | 14.17 | 5.76 | 2.9 |
EBIT | 37.49 | 9.92 | 3.85 | -62.91 | -7.25 | 23.3 |
EBIT Margin | 8.66% | 2.63% | 1.62% | -37.00% | -2.76% | 11.29% |
Effective Tax Rate | 7.37% | - | - | - | - | 6.55% |
Revenue as Reported | 142.64 | 376.97 | 237.08 | 170.01 | 262.89 | 206.48 |